Search Orphan Drug Designations and Approvals
-
Generic Name: | dexamethasone sodium phosphate encapsulated in autologous erythrocytes |
---|---|
Date Designated: | 07/24/2012 |
Orphan Designation: | Treatment of ataxia-telangiectasia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Quince Therapeutics, S.p.A. Via Meucci, 3 Bresso, MI 20091 Italy The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-